Headache; Sinus issues; Issues with her throat; Tiredness; Lymph nodes under arm are swollen and painful/swelling of lymph nodes; Lymph nodes under arm are swollen and painful; Arm is painful; Body aches; Nausea; She is sick.; She does not feel well/feeling unwell; She is irritated; not talkative; pain in the injection site; muscle pain; joint pain; redness on arm; rash on my chest; sore throat; Dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101197920.  A 41-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache"; SINUS DISORDER (non-serious), outcome "unknown", described as "Sinus issues"; PHARYNGEAL DISORDER (non-serious), outcome "unknown", described as "Issues with her throat"; FATIGUE (non-serious), outcome "unknown", described as "Tiredness"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Lymph nodes under arm are swollen and painful/swelling of lymph nodes"; LYMPH NODE PAIN (non-serious), outcome "unknown", described as "Lymph nodes under arm are swollen and painful"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Arm is painful"; PAIN (non-serious), outcome "unknown", described as "Body aches"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; ILLNESS (non-serious), outcome "unknown", described as "She is sick."; MALAISE (non-serious), outcome "unknown", described as "She does not feel well/feeling unwell"; IRRITABILITY (non-serious), outcome "unknown", described as "She is irritated"; SPEECH DISORDER (non-serious), outcome "unknown", described as "not talkative"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "pain in the injection site"; MYALGIA (non-serious), outcome "unknown", described as "muscle pain"; ARTHRALGIA (non-serious), outcome "unknown", described as "joint pain"; ERYTHEMA (non-serious), outcome "unknown", described as "redness on arm"; RASH (non-serious), outcome "unknown", described as "rash on my chest"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat"; DIZZINESS (non-serious), outcome "unknown", described as "Dizziness".  Additional information: This is all after the first shot. the patient wants to know what will happen with the second shot. The patient was not comfortable with getting the second shot. The patient was sick. The patient does not feel well and the patient was not talkative. The patient was irritated and does not feel good.  Attempted to clarify if the caller was wanted to continue with report. Caller commented she did not care then questioned what was a safety report. The patient then mentioned if it was not beneficial to her then the patient did not want to continue. The patient has not felt good for the past few days. The patient just wants to know what do. Her job was making her get the vaccine because it was mandated and now the patient was sick. Caller declined to continue with report. The caller confirmed consent for follow-up, but then when asking for address caller provided it, but when attempting to clarify address caller got upset and questioned what it was for. The caller would not clarify the address/provide ZIP code. The patient just wanted to speak with Medical Information.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (05Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.